Premium
Letter to Dreesen et al. on their article “Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease”—A comprehensive review of infliximab population pharmacokinetic modelling publications
Author(s) -
Le Tilly Olivier,
BejanAngoulvant Theodora,
Paintaud Gilles,
Ternant David
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14554
Subject(s) - infliximab , medicine , pharmacokinetics , ulcerative colitis , population , adalimumab , calprotectin , gastroenterology , faecal calprotectin , inflammatory bowel disease , rheumatoid arthritis , disease , environmental health